Skip to content
LexBuild

Immunology Devices Panel of the Medical Devices Advisory Committee: Notice of Postponement of Meeting

---
identifier: "/us/fr/2011-22767"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Immunology Devices Panel of the Medical Devices Advisory Committee: Notice of Postponement of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2011-22767"
section_name: "Immunology Devices Panel of the Medical Devices Advisory Committee: Notice of Postponement of Meeting"
positive_law: false
currency: "2011-09-07"
last_updated: "2011-09-07"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2011-22767"
document_type: "notice"
publication_date: "2011-09-07"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "76 FR 55398"
fr_volume: 76
docket_ids:
  - "Docket No. FDA-2011-N-0002"
fr_action: "Notice."
---

#  Immunology Devices Panel of the Medical Devices Advisory Committee: Notice of Postponement of Meeting

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is postponing the meeting of the Immunology Devices Panel of the Medical Devices Advisory Committee scheduled for October 14, 2011. The meeting was announced in the *Federal Register* of August 9, 2011 (76 FR 48871). The meeting is postponed so that FDA can review and consider additional information that was submitted. Future meeting dates will be announced in the *Federal Register* .

**FOR FURTHER INFORMATION CONTACT:**

Shanika Craig, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 1613, Silver Spring, MD 20993-0002, 301-796-6639, *e-mail: [email protected],* or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area). Please call the Information Line for up-to-date information on this meeting.

Dated: August 31, 2011.

Leslie Kux,

Acting Assistant Commissioner for Policy.